{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:56:46Z","timestamp":1785175006182,"version":"3.55.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.593917","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T05:18:30Z","timestamp":1603343910000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Is Cyclosporine Ototoxic?"],"prefix":"10.3389","volume":"11","author":[{"given":"Sofia","family":"Waissbluth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"B1","first-page":"433","article-title":"History of the discovery of cyclosporin and of its early pharmacological development","volume":"114","author":"Borel","year":"2002","journal-title":"Wien Klin Wochenschr."},{"key":"B2","first-page":"493","article-title":"Cyclosporine in transplantation - a history of converging timelines","volume":"25","author":"Colombo","year":"2011","journal-title":"J Biol Regul Homeost Agents."},{"key":"B3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/0049-0172(92)90009-3","article-title":"Mechanisms of action of cyclosporine and effects on connective tissues","volume":"21","author":"Russell","year":"1992","journal-title":"Semin Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"12378","DOI":"10.1074\/jbc.273.20.12378","article-title":"T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK\/JNK signaling pathways sensitive to cyclosporin A","volume":"273","author":"Matsuda","year":"1998","journal-title":"J Biol Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/0092-8674(94)90056-6","article-title":"JNK is involved in signal integration during costimulation of T lymphocytes","volume":"77","author":"Su","year":"1994","journal-title":"Cell."},{"key":"B7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bcp.2019.03.022","article-title":"Modulation of innate immunity by cyclosporine A","volume":"163","author":"Liddicoat","year":"2019","journal-title":"Biochem Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e1499388","DOI":"10.1080\/2162402X.2018.1499388","article-title":"MDR1 in immunity: friend or foe?","volume":"7","author":"Bossennec","year":"2018","journal-title":"Oncoimmunology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4137\/DTI.S12519","article-title":"P-glycoprotein inhibition for optimal drug delivery","volume":"7","author":"Amin","year":"2013","journal-title":"Drug Target Insights."},{"key":"B10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1146\/annurev.me.37.020186.001243","article-title":"Action and toxicity of cyclosporine","volume":"37","author":"Bennett","year":"1986","journal-title":"Annu Rev Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s004150050360","article-title":"Cyclosporine neurotoxicity: a review","volume":"246","author":"Gijtenbeek","year":"1999","journal-title":"J Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3949\/ccjm.61.4.308","article-title":"Cyclosporine: mechanisms of action and toxicity","volume":"61","author":"Graham","year":"1994","journal-title":"Cleve Clin J Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jconrel.2016.01.056","article-title":"Reformulating cyclosporine A (CsA): more than just a life cycle management strategy","volume":"225","author":"Guada","year":"2016","journal-title":"J Control Release."},{"key":"B14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2215\/CJN.03791106","article-title":"Therapeutic monitoring of calcineurin inhibitors for the nephrologist","volume":"2","author":"Schiff","year":"2007","journal-title":"Clin J Am Soc Nephrol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/00007890-199511150-00012","article-title":"Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis","volume":"60","author":"Kalhs","year":"1995","journal-title":"Transplantation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0378-5955(99)00035-0","article-title":"Expression pattern of adenylyl cyclase isoforms in the inner ear of the rat by RT-PCR and immunochemical localization of calcineurin in the organ of Corti","volume":"132","author":"Kumagami","year":"1999","journal-title":"Hear Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.heares.2017.12.009","article-title":"Immune cells and non-immune cells with immune function in mammalian cochleae","volume":"362","author":"Hu","year":"2018","journal-title":"Hear Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1084713811408349","article-title":"Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis","volume":"15","author":"Kuhn","year":"2011","journal-title":"Trends Amplif."},{"key":"B19","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MAO.0000000000001396","article-title":"Diagnosis and treatment of vestibular neuritis\/neuronitis or peripheral vestibulopathy (PVP)? Open Questions and Possible Answers","volume":"38","author":"Hegemann","year":"2017","journal-title":"Otol Neurotol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-0040-1715728","article-title":"Magnesium and hearing","volume":"14","author":"Cevette","year":"2003","journal-title":"J Am Acad Audiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/0394632016673845","article-title":"Sudden sensorineural hearing loss: is there a connection with inner ear electrolytic disorders? A literature review","volume":"29","author":"Ciorba","year":"2016","journal-title":"Int J Immunopathol Pharmacol."},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1017\/UPO9780987073051.011","article-title":"Magnesium and hearing loss","volume-title":"Magnesium in the Central Nervous System","author":"Sendowski","year":"2011"},{"key":"B23","doi-asserted-by":"publisher","first-page":"472","DOI":"10.2165\/00003088-199324060-00004","article-title":"Cyclosporin clinical pharmacokinetics","volume":"24","author":"Fahr","year":"1993","journal-title":"Clin Pharmacokinet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"eaao0935","DOI":"10.1126\/scitranslmed.aao0935","article-title":"Delivery of therapeutics to the inner ear: the challenge of the blood-labyrinth barrier","volume":"11","author":"Nyberg","year":"2019","journal-title":"Sci Transl Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.heares.2011.08.006","article-title":"Physiopathology of the cochlear microcirculation","volume":"282","author":"Shi","year":"2011","journal-title":"Hear Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21608\/geget.2019.38023","article-title":"Hearing status in children with idiopathic nephrotic syndrome","volume":"14","author":"Ibrahim","year":"2019","journal-title":"Geget."},{"key":"B27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1080\/14992027.2017.1329556","article-title":"Cyclosporine causes no hearing defect in paediatric patients with nephrotic syndrome","volume":"56","author":"Kasap-Demir","year":"2017","journal-title":"Int J Audiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"324","DOI":"10.6002\/ect.2014.0158","article-title":"Hearing status in pediatric renal transplant recipients","volume":"13","author":"Gulleroglu","year":"2015","journal-title":"Exp Clin Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/lt.21385","article-title":"Audiometric changes in patients undergoing liver transplantation using distinct immunosuppressive protocols","volume":"14","author":"Fortes","year":"2008","journal-title":"Liver Transpl."},{"key":"B30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/lt.20610","article-title":"A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation","volume":"12","author":"Rifai","year":"2006","journal-title":"Liver Transpl."},{"key":"B31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/01.TP.0000128616.02821.8B","article-title":"Long-term follow-up of renal transplantation in children: a Dutch cohort study","volume":"78","author":"Groothoff","year":"2004","journal-title":"Transplantation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/00007890-199802270-00009","article-title":"Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group","volume":"65","author":"Cole","year":"1998","journal-title":"Transplantation."},{"key":"B33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/0194599815624407","article-title":"Clinical practice guideline: otitis media with effusion executive summary (update)","volume":"154","author":"Rosenfeld","year":"2016","journal-title":"Otolaryngol Head Neck Surg."},{"key":"B34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000187158","article-title":"Sudden hearing loss in a cyclosporin-treated renal transplantation patient","volume":"63","author":"Arinsoy","year":"1993","journal-title":"Nephron."},{"key":"B35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0002-9394(98)00137-8","article-title":"Cyclosporine-induced optic neuropathy, ophthalmoplegia, and nystagmus in a patient with Crohn disease","volume":"126","author":"Porges","year":"1998","journal-title":"Am J Ophthalmol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1080\/00016480410016225","article-title":"Progressive bilateral sensorineural hearing loss probably induced by chronic cyclosporin A treatment after renal transplantation for focal glomerulosclerosis","volume":"124","author":"Marioni","year":"2004","journal-title":"Acta Otolaryngol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s40800-015-0023-3","article-title":"Accidental overdose of oral cyclosporine in haematopoietic stem cell transplantation: a case report and literature review","volume":"2","author":"Tafazoli","year":"2015","journal-title":"Drug Saf Case Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00467-012-2358-7","article-title":"Hearing status in children with frequently relapsing and steroid resistant nephrotic syndrome","volume":"28","author":"Saha","year":"2013","journal-title":"Pediatr Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.4103\/tcmj.tcmj_149_17","article-title":"Sensorineural hearing loss in patients with chronic renal failure on hemodialysis in Basrah, Iraq","volume":"30","author":"Saeed","year":"2018","journal-title":"Ci Ji Yi Xue Za Zhi."},{"key":"B40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.joto.2016.10.001","article-title":"Ototoxic effects and mechanisms of loop diuretics","volume":"11","author":"Ding","year":"2016","journal-title":"J Otol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/00007691-199111000-00001","article-title":"Factors influencing the pharmacokinetics of cyclosporine in man","volume":"13","author":"Lindholm","year":"1991","journal-title":"Ther Drug Monit."},{"key":"B42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/00016480152602212","article-title":"Doxorubicin ototoxicity is induced in mice by combination treatment with cyclosporin A","volume":"121","author":"Saito","year":"2001","journal-title":"Acta Otolaryngol."},{"key":"B43","first-page":"499","article-title":"Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss","volume":"21","author":"Yang","year":"2000","journal-title":"Am J Otol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","article-title":"An integrated view of cisplatin-induced nephrotoxicity and ototoxicity","volume":"237","author":"Karasawa","year":"2015","journal-title":"Toxicol Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1177\/0897190014546836","article-title":"Aminoglycoside-induced nephrotoxicity","volume":"27","author":"Wargo","year":"2014","journal-title":"J Pharm Pract."},{"key":"B46","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2165\/00002018-200831100-00006","article-title":"Drug-related nephrotoxic and ototoxic reactions: a link through a predictive mechanistic commonality","volume":"31","author":"Verdel","year":"2008","journal-title":"Drug Saf."},{"key":"B47","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1523-1755.2004.00390.x","article-title":"Ear and kidney syndromes: molecular versus clinical approach","volume":"65","author":"Izzedine","year":"2004","journal-title":"Kidney Int."},{"key":"B48","unstructured":"2020"},{"key":"B49","unstructured":"2020"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.593917\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T06:35:10Z","timestamp":1669271710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2020.593917\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":49,"alternative-id":["10.3389\/fneur.2020.593917"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.593917","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"article-number":"593917"}}